AMICUS THERAPEUTICS, INC. — Director's Dealing 2020

Dec 17, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS, INC. (FOLD)
CIK: 0001178879
Period of Report: 2020-12-15

Reporting Person: Quimi Daphne (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-12-15	Common Stock	M	11500	$2.94	Acquired	229679	Direct
2020-12-15	Common Stock	M	7550	$4.38	Acquired	237229	Direct
2020-12-15	Common Stock	M	4379	$3.53	Acquired	241608	Direct
2020-12-15	Common Stock	M	6892	$2.45	Acquired	248500	Direct
2020-12-15	Common Stock	F	4156	$23.86	Disposed	244344	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-12-15	Stock Options (right to buy)	$2.94	M	11500	Disposed	2024-06-26	Common Stock (11500)	Direct
2020-12-15	Stock Options (right to buy)	$4.38	M	7550	Disposed	2022-06-04	Common Stock (7550)	Direct
2020-12-15	Stock Options (right to buy)	$3.53	M	4379	Disposed	2023-01-28	Common Stock (4379)	Direct
2020-12-15	Stock Options (right to buy)	$2.45	M	6892	Disposed	2024-01-03	Common Stock (6892)	Direct

Footnotes

F1: Represents shares swapped to cover the strike price of the options exercised.

F2: All of the options were fully vested and exercisable as of the transaction date.